The largest database of trusted experimental protocols

13 protocols using dh5a competent cells

1

Cre and Fluorescent Protein Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
pCAG-Cre, pCALNL-EGFP, pCALNL-DsRed are a generous gift from CL Cepko and are currently available through Addgene (plasmids 13775, 13770, 13769). All plasmids were grown in DH5a competent cells (Life Technologies) and purified using endotoxin-free maxiprep kits (Qiagen)45 (link).
+ Open protocol
+ Expand
2

Cre-LoxP Fluorescent Reporter Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
pCAG-Cre, pCALNL-EGFP, pCALNL-DsRed are a generous gift from T. Matsuda & C. L. Cepko and are currently available through Addgene (plasmids 13775, 13770, 13769). pEGFP-N1 was from Clontech. mCherry was a generous gift from Dr. Roger Tsien. All plasmids were grown in DH5a competent cells (Life Technologies) and purified using endotoxin-free maxiprep kits (Qiagen).
+ Open protocol
+ Expand
3

TALEN Design for Targeting kif6 Exon

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two TALENs (left and right) were designed to target the second exon of kif6. These sites flanked a BccI restriction site that was used for mutation screening. TALENs were generated using the Golden Gate method as previously described (Cermak et al., 2011 (link)). Plasmids were acquired from the Golden Gate TALEN and TAL Effector Kit (AddGene) and RVD repeat arrays were cloned into pCS2TAL3DD and pCS2TAL3RR (AddGene). Plasmids were transformed into DH5a competent cells (Invitrogen) and isolated using the QIAprep Spin Miniprep Kit (Qiagen). The following sequence targets and RVD sites were used to generate kif6 TALENs: Left target DNA TCCCTCTTATTGTTG, LeftRVDsequence NGHDHDHDNGHD NGNGNINGNGNNNGNGNN Right target DNA GCATCTCTGGGAACC RightRVDsequence NNNNNGNGHDHDHDNINN NINNNINGNNHD
+ Open protocol
+ Expand
4

Quantification of DENV3 Viral RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The DENV3 viral RNA standard was prepared by amplifying a 464-bp fragment of DENV3 strain (GI:163644368) with primers 5′-ACAGTTTCGACTCGG-3′ (corresponding to genome position 29 to 43) and 5′-CTTTCATTCTTCCCC-3′ (corresponding to genome position 492 to 478). The resulting product was ligated into pGEM-T Easy vector (Promega) and transformed in DH5a competent cells (Invitrogen). Minipreps of isolated plasmid DNA were then prepared (Promega). RNA transcripts were generated using the Megascript kit according to the manufacturer’s specifications, and the RNA concentration was determined by UV spectrophotometry. Primers (DV3-qF 5′-AACCGTGTGTCAACTGGATCA-3′ and DV3-qR 5′-TTAATGGCCCCCGACTTCTT-3′) were designed to target the DENV pre-membrane region (prM) within the viral RNA standard that was previously designed. Real-time PCR was conducted using SYBRGreen I Mastermix (Applied Biosystems) on a Bio-Rad CFX96 detection instrument. Amplification conditions were 95 °C for 30 s, and 40 cycles of 95 °C for 5 s, 55 °C for 20 s, and 72 °C for 30 s. Viral genome copy numbers were calculated from a standard curve generated by an in vitro transcribed RNA standard.
+ Open protocol
+ Expand
5

Recombinant sIFNAR2 Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
A study of the cloning of the recombinant protein has previously been published [18 (link),19 (link)]. Briefly, the prokaryotic expression system pEcoli-Cterm 6xHN Linear (Clontech®, Mountain View, CA, USA) was chosen to ligate the sIFNAR2 insert. DH5a Competent Cells™ (Invitrogen®, Carlsbad, CA, USA) were transformed with the plasmid and the colony, forming isolated units. After plasmid purification (PureYield™ (Promega®, Madison, WI, USA)), BL21 (DE3) (Invitrogen®) bacteria were transformed to produce the recombinant sIFNAR2. This was purified on high-capacity Ni+2-iminodiacetic acid resin columns, detected by Western Blot using anti-IFNAR2 Human MaxPab antibody (Abnova®, Taipei, Taiwan), and its identity was confirmed by the matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry. The recombinant protein had 239 amino acids and a molecular mass of 29 kDa, and its sequence corresponded to IFNAR2.3 (uniprot: P48551-3). Supplementary Figure S1 shows the identification of the protein by Western blot and by mass spectrometry.
+ Open protocol
+ Expand
6

Cultivation and Preservation of Cenococcum and Microbes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cenococcum geophilum isolates originating from different sites (Supplementary Table S1) were kept in Petri dishes (100 × 20 mm) containing Cenococcum medium, a modified MMN medium containing casein (Trappe, 1962 ), at 25°C and transferred to new culture medium every 20 days. Escherichia coli (subcloning efficiency DH5a competent cells; Invitrogen, Carlsbad, CA, U.S.A.) and Agrobacterium tumefaciens (electrocompetent strain GV3101) were conserved at −80°C and they were grown in LB and YEPD medium at 37 and 28°C, respectively.
+ Open protocol
+ Expand
7

Plasmid Cloning and Sequencing of PCR Products

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 3′ and 5′ sequences of PCR products derived from MS-HRM using primer 1 were digested with BamH1 and EcoR1 and ligated into a pBluescript II plasmid using 2× ligation mix (Wako); subcloning-efficient DH5a-competent cells (Invitrogen) were used for transformation. Primer 1 was the sequencing primer. PCR products derived from 25 colonies of each sample were used for the sequencing reaction using BigDye Terminator v1.1 (Applied Biosystems) according to the manufacturer's instructions. The cycling conditions were 60 seconds at 96°C; and 25 cycles of 30 seconds at 96°C, 5 seconds at 50°C, and 4 minutes at 60°C. The PCR products were cleaned using Centri-Sep Spin Columns (Thermo Fisher Scientific) and then sequenced on an ABI PRISM 310 genetic analyzer (Applied Biosystems).
+ Open protocol
+ Expand
8

Constructing pAAV-Ef1a-Lin28a-FLAG Plasmid

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pAAV-Ef1a-Lin28a-FLAG plasmid was constructed in a previous study (Wang et al., 2018 (link)). Briefly, the Lin28a-FLAG open reading frame with a 5’ BamHI and a 3’ EcoRV restriction sites was synthesized (codon optimized, gBlocks of Integrated DNA Technologies) and used to replace the EYFP open reading frame in pAAV-Ef1a-EYFP, to obtain the pAAV-Ef1a-Lin28a-FLAG plasmid. All restriction enzymes and T4 DNA ligase were purchased from New England Biolabs. Plasmids were amplified using DH5a competent cells (Thermo Fisher Scientific) and purified with Endofree plasmid maxi kit (QIAGEN).
+ Open protocol
+ Expand
9

Constructing pAAV-Ef1a-Lin28a-FLAG Plasmid

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pAAV-Ef1a-Lin28a-FLAG plasmid was constructed in a previous study (Wang et al., 2018 (link)). Briefly, the Lin28a-FLAG open reading frame with a 5’ BamHI and a 3’ EcoRV restriction sites was synthesized (codon optimized, gBlocks of Integrated DNA Technologies) and used to replace the EYFP open reading frame in pAAV-Ef1a-EYFP, to obtain the pAAV-Ef1a-Lin28a-FLAG plasmid. All restriction enzymes and T4 DNA ligase were purchased from New England Biolabs. Plasmids were amplified using DH5a competent cells (Thermo Fisher Scientific) and purified with Endofree plasmid maxi kit (QIAGEN).
+ Open protocol
+ Expand
10

Generation and Characterization of EPE Mutant Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
EPE Mutant mice were generated as previously described(Wang et al., 2013 (link)). Oligos were ordered from Integrated DNA Technologies and the gRNA sequences used were: TCF-EPE gRNA1-ATAACTGCCGAGGTTAGATT and TCF-EPE gRNA2-AAGCAGCG-TATCTACGGCAG. gRNA were synthesized in vitro with HiScribe T7 High Yield RNA Synthesis Kit (New England Biolabs, #E2040S), and purified with RNA Clean & Concentrator (Zymo Research, #R1015) according to manufacturer’s protocol. Cas9 protein (PNA Bio, #CP03) 30 ng/µl, two gRNAs each 0.3 µM were mixed according to PNA Bio protocol. 10 µl of the mixture was micro-injected into each embryonic zygote. Genomic DNA was isolated from transgenic mice tail with DNeasy Blood & Tissue Kits (QIAGEN, #69506) and used for genotyping using the following oligos: TCF-EPE F - AGTCACAGGAGGGCGTACGG and TCF-EPE R – GCAGCCTGTCCTAGTCCCAGG. Purified PCR products were further cloned into pGEM®-T Vector Systems (Promega, #A3600), transformed into DH5a competent cells (Thermo Fisher Scientific, #18258012), and sequenced by GENEWIZ.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!